Antisocial personality disorder: treatment, management and prevention. Clinical Guideline CG77 (28th January 2009)
Antisocial personality disorder is the name given to a condition that affects a person's thoughts, emotions and behaviour. Antisocial means behaving in a way that is disruptive to, and may be harmful to, other people. The advice in the NICE guideline covers:
Autologous blood injection for tendinopathy. Interventional Procedure Guidance IPG279 (28th January 2009)
Tendonitis is the inflammation of the tendon - the fibrous tissue that connects muscles to bones - which may occur through overuse. In this treatment, blood is taken from the patient (which is sometimes treated in the laboratory) and then re-injected around the affected tendon to supply growth factors that initiate healing.
IP Guidance
Borderline personality disorder: treatment and management. Clinical Guideline CG78 (28th January 2009)
This guideline covers:
Functional electrical stimulation for drop foot of central neurological origin. Interventional Procedure IPG27 (28th January 2009)
Drop foot is the inability to lift the foot and toes when walking. It can result from conditions such as stroke, multiple sclerosis or spinal cord injury. Functional electrical stimulation involves stimulation of the peripheral nerves that supply the paralysed muscle using electrodes that may be implanted or placed on the surface of the skin. The aim is to restore muscular function.
IP Guidance
Cochlear implants for severe to profound deafness in children and adults. Technology Appraisal TA166 (28th January 2009)
A cochlear implant in one ear is recommended as a possible option for everyone with severe to profound deafness if they do not get enough benefit from hearing aids after trying them for 3 months. Cochlear implants in both ears are recommended for the following groups with severe to profound deafness only if they do not get enough benefit from hearing aids after trying them for 3 months and the implants are placed during the same operation:
Infracoccygeal sacropexy using mesh for uterine prolapse repair. Interventional Procedure IPG280 (28th January 2009)
NICE was notified of various procedures for the treatment of pelvic organ prolapse. NICE asked the Review Body for Interventional Procedures to undertake a systematic review of these procedures.The Interventional Procedures Advisory Committee (IPAC) considered the systematic review and have also produced guidance on: infracoccygeal sacropexy using mesh for vaginal vault prolapse repair, sacrocolpopexy using mesh for vaginal vault prolapse repair, sacrocolpopexy using mesh for uterine prolapse repair and insertion of uterine suspension sling (including sacrohysteropexy) using mesh for uterine prolapse repair.
Uterine prolapse occurs when the womb (uterus) slips down from its normal position into the vagina. Infracoccygeal sacropexy is an operation that involves the insertion of a piece of material (mesh) with the aim of holding the womb in place.
IP Guidance
Antisocial personality disorder is the name given to a condition that affects a person's thoughts, emotions and behaviour. Antisocial means behaving in a way that is disruptive to, and may be harmful to, other people. The advice in the NICE guideline covers:
- The care, treatment and support that people with antisocial personality disorder and their families or carers should be offered
- The care and treatment that children with conduct problems and their families or carers should be offered.
Autologous blood injection for tendinopathy. Interventional Procedure Guidance IPG279 (28th January 2009)
Tendonitis is the inflammation of the tendon - the fibrous tissue that connects muscles to bones - which may occur through overuse. In this treatment, blood is taken from the patient (which is sometimes treated in the laboratory) and then re-injected around the affected tendon to supply growth factors that initiate healing.
IP Guidance
Borderline personality disorder: treatment and management. Clinical Guideline CG78 (28th January 2009)
This guideline covers:
- The care, treatment and support that people with borderline personality disorder should be offered.
Functional electrical stimulation for drop foot of central neurological origin. Interventional Procedure IPG27 (28th January 2009)
Drop foot is the inability to lift the foot and toes when walking. It can result from conditions such as stroke, multiple sclerosis or spinal cord injury. Functional electrical stimulation involves stimulation of the peripheral nerves that supply the paralysed muscle using electrodes that may be implanted or placed on the surface of the skin. The aim is to restore muscular function.
IP Guidance
Cochlear implants for severe to profound deafness in children and adults. Technology Appraisal TA166 (28th January 2009)
A cochlear implant in one ear is recommended as a possible option for everyone with severe to profound deafness if they do not get enough benefit from hearing aids after trying them for 3 months. Cochlear implants in both ears are recommended for the following groups with severe to profound deafness only if they do not get enough benefit from hearing aids after trying them for 3 months and the implants are placed during the same operation:
- children
- adults who are blind or have other disabilities which mean that they depend upon hearing sounds for spatial awareness.
Infracoccygeal sacropexy using mesh for uterine prolapse repair. Interventional Procedure IPG280 (28th January 2009)
NICE was notified of various procedures for the treatment of pelvic organ prolapse. NICE asked the Review Body for Interventional Procedures to undertake a systematic review of these procedures.The Interventional Procedures Advisory Committee (IPAC) considered the systematic review and have also produced guidance on: infracoccygeal sacropexy using mesh for vaginal vault prolapse repair, sacrocolpopexy using mesh for vaginal vault prolapse repair, sacrocolpopexy using mesh for uterine prolapse repair and insertion of uterine suspension sling (including sacrohysteropexy) using mesh for uterine prolapse repair.
Uterine prolapse occurs when the womb (uterus) slips down from its normal position into the vagina. Infracoccygeal sacropexy is an operation that involves the insertion of a piece of material (mesh) with the aim of holding the womb in place.
IP Guidance
Infracoccygeal sacropexy using mesh for vaginal vault prolapse repair. Interventional Procedure IPG281 (28th January 2009)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on infracoccygeal sacropexy using mesh for vaginal vault prolapse repair .
It replaces the previous guidance on posterior infracoccygeal sacropexy for vaginal vault prolapse (Interventional Procedures Guidance no. 125, May 2005).
Vaginal vault prolapse occurs in wome with previous surgical removal of the womb when the upper vaginal wall slips down from its normal position down into the vaginal canal or outside of the vagina. Infracoccygeal sacropexy is an operation that involves the insertion of a piece of material (mesh) with the aim of holding the vaginal vault in place.
IP Guidance
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on infracoccygeal sacropexy using mesh for vaginal vault prolapse repair .
It replaces the previous guidance on posterior infracoccygeal sacropexy for vaginal vault prolapse (Interventional Procedures Guidance no. 125, May 2005).
Vaginal vault prolapse occurs in wome with previous surgical removal of the womb when the upper vaginal wall slips down from its normal position down into the vaginal canal or outside of the vagina. Infracoccygeal sacropexy is an operation that involves the insertion of a piece of material (mesh) with the aim of holding the vaginal vault in place.
IP Guidance
Insertion of mesh uterine suspension sling (including sacrohysteropexy) for uterine prolapse repair. Interventional Procedure IPG282 (28th January 2009)
NICE was notified of various procedures for the treatment of pelvic organ prolapse. NICE asked the Review Body for Interventional Procedures to undertake a systematic review of these procedures.The Interventional Procedures Advisory Committee (IPAC) considered the systematic review and have also produced guidance on: sacrocolpopexy using mesh for vaginal vault prolapse repair, sacrocolpopexy using mesh for uterine prolapse repair, infracoccygeal sacropexy using mesh for vaginal vault prolapse repair and infracoccygeal sacropexy using mesh for uterine prolapse repair.
Uterine prolapse occurs when the womb slips down from its normal position into the vagina. Uterine suspension sling involves an operation to insert a piece of material (mesh) with the aim of holding the womb in place.
IP Guidance
Sacrocolpopexy using mesh for vaginal vault prolapse repair. Interventional Procedure IPG283 (28th January 2009)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on sacrocolpopexy using mesh for vaginal vault prolapse repair.
It replaces the previous guidance on mesh sacrocolpopexy for vaginal vault prolapse (Interventional Procedures Guidance no. 215, March 2007).
Vaginal vault prolapse occurs when organs above or around the vagina slip down from their normal position. Sacrocolpopexy is an operation that aims to provide support for the pelvic organs in their natural position. This is achieved by attaching a piece of material (mesh), usually from the top and back of the vagina, to a ligament of the lower back bone.
IP Guidance
Sacrocolpopexy with hysterectomy using mesh for uterine prolapse repair. Interventional Procedure IPG284 (28th January 2009)
NICE was notified of various procedures for the treatment of pelvic organ prolapse. NICE asked the Review Body for Interventional Procedures to undertake a systematic review of these procedures.The Interventional Procedures Advisory Committee (IPAC) considered the systematic review and have also produced guidance on: sacrocolpopexy using mesh for vaginal vault prolapse repair, infracoccygeal sacropexy using mesh for vaginal vault prolapse repair, infracoccygeal sacropexy using mesh for uterine prolapse repair and insertion of uterine suspension sling (including sacrohysteropexy) using mesh for uterine prolapse repair.
Uterine prolapse occurs when the womb (uterus) slips down from its normal position into the vagina. Sacrocolpopexy is an operation involving the insertion of a piece of material (mesh) with the aim of holding the pelvic organs in place, following surgical removal of the womb.
IP Guidance
Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical Guideline CG76 (28th January 2009)
This guidance is about enabling patients to make informed choices by involving and supporting them in decisions about prescribed medicines. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence) to the NHS in England and Wales.
Clinical Guideline
Machine perfusion systems and cold static storage of kidneys from deceased donors. Technology Appraisal TA165 (28th January 2009)
NICE was notified of various procedures for the treatment of pelvic organ prolapse. NICE asked the Review Body for Interventional Procedures to undertake a systematic review of these procedures.The Interventional Procedures Advisory Committee (IPAC) considered the systematic review and have also produced guidance on: sacrocolpopexy using mesh for vaginal vault prolapse repair, sacrocolpopexy using mesh for uterine prolapse repair, infracoccygeal sacropexy using mesh for vaginal vault prolapse repair and infracoccygeal sacropexy using mesh for uterine prolapse repair.
Uterine prolapse occurs when the womb slips down from its normal position into the vagina. Uterine suspension sling involves an operation to insert a piece of material (mesh) with the aim of holding the womb in place.
IP Guidance
Sacrocolpopexy using mesh for vaginal vault prolapse repair. Interventional Procedure IPG283 (28th January 2009)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on sacrocolpopexy using mesh for vaginal vault prolapse repair.
It replaces the previous guidance on mesh sacrocolpopexy for vaginal vault prolapse (Interventional Procedures Guidance no. 215, March 2007).
Vaginal vault prolapse occurs when organs above or around the vagina slip down from their normal position. Sacrocolpopexy is an operation that aims to provide support for the pelvic organs in their natural position. This is achieved by attaching a piece of material (mesh), usually from the top and back of the vagina, to a ligament of the lower back bone.
IP Guidance
Sacrocolpopexy with hysterectomy using mesh for uterine prolapse repair. Interventional Procedure IPG284 (28th January 2009)
NICE was notified of various procedures for the treatment of pelvic organ prolapse. NICE asked the Review Body for Interventional Procedures to undertake a systematic review of these procedures.The Interventional Procedures Advisory Committee (IPAC) considered the systematic review and have also produced guidance on: sacrocolpopexy using mesh for vaginal vault prolapse repair, infracoccygeal sacropexy using mesh for vaginal vault prolapse repair, infracoccygeal sacropexy using mesh for uterine prolapse repair and insertion of uterine suspension sling (including sacrohysteropexy) using mesh for uterine prolapse repair.
Uterine prolapse occurs when the womb (uterus) slips down from its normal position into the vagina. Sacrocolpopexy is an operation involving the insertion of a piece of material (mesh) with the aim of holding the pelvic organs in place, following surgical removal of the womb.
IP Guidance
Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical Guideline CG76 (28th January 2009)
This guidance is about enabling patients to make informed choices by involving and supporting them in decisions about prescribed medicines. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence) to the NHS in England and Wales.
Clinical Guideline
Machine perfusion systems and cold static storage of kidneys from deceased donors. Technology Appraisal TA165 (28th January 2009)
The following methods are recommended for storing kidneys from donors who have died:
- machine perfusion using the LifePort kidney transporter
- cold static storage using Belzer UW storage solution or Marshall's hypertonic citrate solution
- the expertise and equipment available to the teams collecting the kidney
- how the teams are organised, and
- the distances involved
Promoting physical activity, active play and sport for pre-school and school-age children and young people in family, pre-school, school and community settings. Publich Health Guidance PH17 (28th January 2009)
This guidance is for all those who have a direct or indirect role in - and responsibility for - promoting physical activity for children and young people. It complements and supports, but does not replace, NICE guidance on obesity, physical activity, physical activity and the environment, depression among children and young people and social and emotional wellbeing in schools.
PH Guidance
Ultrasound-guided regional nerve block. Interventional Procedure IPG285 (28th January 2009)
There are a number of conditions for which regional anaesthesia to allow surgery is required for a specific part of the body. This technique aims to provide accurate placement of local anaesthetic by using ultrasound guidance to position needles that deliver the local anaesthetic in the correct place next to the nerves.
IP Guidance
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation. Interventional Procedure IPG286 (28th January 2009)
Atrial fibrillation is a condition that affects the heart, causing an irregular pulse. It occurs when the electrical impulses controlling the heartbeat become disorganised, so that the heart beats irregularly and too fast. When this happens, the heart cannot efficiently pump blood around the body. This may cause symptoms such as palpitations, chest pain or discomfort, shortness of breath, dizziness and fainting. Atrial fibrillation increases the risk of blood clots and stroke. In thoracoscopic epicardial radiofrequency ablation, selected areas of the heart are destroyed using heat, with the aim of preventing the occurrence or conduction of abnormal electrical activity. The procedure is done through small incisions in the chest and using a camera.
IP Guidance
This guidance is for all those who have a direct or indirect role in - and responsibility for - promoting physical activity for children and young people. It complements and supports, but does not replace, NICE guidance on obesity, physical activity, physical activity and the environment, depression among children and young people and social and emotional wellbeing in schools.
PH Guidance
Ultrasound-guided regional nerve block. Interventional Procedure IPG285 (28th January 2009)
There are a number of conditions for which regional anaesthesia to allow surgery is required for a specific part of the body. This technique aims to provide accurate placement of local anaesthetic by using ultrasound guidance to position needles that deliver the local anaesthetic in the correct place next to the nerves.
IP Guidance
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation. Interventional Procedure IPG286 (28th January 2009)
Atrial fibrillation is a condition that affects the heart, causing an irregular pulse. It occurs when the electrical impulses controlling the heartbeat become disorganised, so that the heart beats irregularly and too fast. When this happens, the heart cannot efficiently pump blood around the body. This may cause symptoms such as palpitations, chest pain or discomfort, shortness of breath, dizziness and fainting. Atrial fibrillation increases the risk of blood clots and stroke. In thoracoscopic epicardial radiofrequency ablation, selected areas of the heart are destroyed using heat, with the aim of preventing the occurrence or conduction of abnormal electrical activity. The procedure is done through small incisions in the chest and using a camera.
IP Guidance
Quitting smoking in pregnancy and following childbirth - draft scope consultation (23rd January 2009)
NICE is developing public health intervention guidance: How to stop smoking in pregnancy and following childbirth. Closing date for comments is 20th February 2009.
Consultation
Interventional procedure overview of tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) (interventional procedures second consultation) (27th January 2009)
Nystagmus is the involuntary movement of the eyes (most commonly from side to side) and is usually associated with impaired vision. Tenotomy involves cutting the horizontal muscles of the eye (which move the eye from side to side) and reattaching them at the same place. The aim of the procedure is to improve vision. Closing date for comments is 24th February 2009.
Consultation
Percutaneous endoscopic laser lumbar discectomy (interventional procedures consultation) (27th January 2009)
Symptomatic lumbar disc prolapse occurs when a disc at the lower end of the back bursts and pushes against spinal nerves. This may cause pain in the back or legs, and weakness and numbness in the legs. The aim of a percutaneous endoscopic laser lumbar discectomy is to remove the part of the disc that is pushing against the spinal nerve root. A small cut is made in the skin and a small flexible camera is inserted though the cut. This allows use of special equipment including a laser to heat and destroy some of the disc and remove its protruding part. Closing date for comments is 24th February 2009.
Consultation
Transmyocardial laser revascularisation for refractory angina pectoris (interventional procedures consultation) (27th January 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Transmyocardial laser revascularisation involves open heart surgery to drill holes on the heart muscle using a laser beam, with the aim of enabling blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain. Closing date for comments is 24th February 2009.
Consultation
Percutaneous laser revascularisation for refractory angina pectoris (interventional procedures consulation) (27th January 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Percutaneous laser revascularisation involves insertion of a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam. The aim is to enable blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain. Closing date for comments is 24th February 2009.
Consultation
How to put NICE guidance into practice and improve the health and well being of communities: practical steps for local authorities (28th February 2009)
Following two stakeholder workshops in May of this year, NICE has developed a “How to” guide to implementation that aims to support Local Authorities with the implementation of NICE guidance. This guide was launched at the NICE conference in December 2008. The guide is split into 3 parts:
Part 1 discusses getting started with the process of implementation of NICE Guidance
Part 2 outlines the principles of implementation of NICE guidance
Part 3 discusses the practical steps to implementation of NICE guidance
Feedback is welcomed by 11th February 2009.
Guide
Head and neck cancer (squamous cell carcinoma) - cetuximab (appraisal consultation document) (29th January 2009)
The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck. Closing date for comments is 19th February 2009.
Consultation
Promoting mental wellbeing at work: consultation on the evidence, January 2009 (29th January 2009)
The aim of this consultation is to enable stakeholders to consider the evidence gathered and to provide the opportunity to comment, in particular on:
Consultation
Multiple myeloma - lenalidomide: appraisal consultation document 2 (29th January 2009)
The Appraisal Committee has had its second meeting following consultation on the first appraisal consultation document, to consider the updated analysis submitted by the manufacturer. It also considered views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of lenalidomide. Closing date for comments is 20th February 2009.
Consultation
NHS Evidence: draft accreditation process manual public consultation (2nd February 2009)
This draft ‘Process manual for accrediting producers of guidance and recommendations for practice: a guide for producers and stakeholders’ describes the process for accrediting producers of guidance and recommendations for practice. It provides details on the scope for accreditation and what types of guidance producers are accredited, the criteria used to perform the accreditation assessment, the main steps in the process for reaching an accreditation decision and the notification and publication process of an accreditation decision. Closing date for comments is 1st May 2009.
Consultation
Epilepsy (update): scope consultation (3rd February 2009)
NICE have been asked to develop a clinical practice guideline on Epilepsy for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for the Epilepsy (update) guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline. Closing date for comments is 2nd March 2009.
Consultation
NICE is developing public health intervention guidance: How to stop smoking in pregnancy and following childbirth. Closing date for comments is 20th February 2009.
Consultation
Interventional procedure overview of tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) (interventional procedures second consultation) (27th January 2009)
Nystagmus is the involuntary movement of the eyes (most commonly from side to side) and is usually associated with impaired vision. Tenotomy involves cutting the horizontal muscles of the eye (which move the eye from side to side) and reattaching them at the same place. The aim of the procedure is to improve vision. Closing date for comments is 24th February 2009.
Consultation
Percutaneous endoscopic laser lumbar discectomy (interventional procedures consultation) (27th January 2009)
Symptomatic lumbar disc prolapse occurs when a disc at the lower end of the back bursts and pushes against spinal nerves. This may cause pain in the back or legs, and weakness and numbness in the legs. The aim of a percutaneous endoscopic laser lumbar discectomy is to remove the part of the disc that is pushing against the spinal nerve root. A small cut is made in the skin and a small flexible camera is inserted though the cut. This allows use of special equipment including a laser to heat and destroy some of the disc and remove its protruding part. Closing date for comments is 24th February 2009.
Consultation
Transmyocardial laser revascularisation for refractory angina pectoris (interventional procedures consultation) (27th January 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Transmyocardial laser revascularisation involves open heart surgery to drill holes on the heart muscle using a laser beam, with the aim of enabling blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain. Closing date for comments is 24th February 2009.
Consultation
Percutaneous laser revascularisation for refractory angina pectoris (interventional procedures consulation) (27th January 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Percutaneous laser revascularisation involves insertion of a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam. The aim is to enable blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain. Closing date for comments is 24th February 2009.
Consultation
How to put NICE guidance into practice and improve the health and well being of communities: practical steps for local authorities (28th February 2009)
Following two stakeholder workshops in May of this year, NICE has developed a “How to” guide to implementation that aims to support Local Authorities with the implementation of NICE guidance. This guide was launched at the NICE conference in December 2008. The guide is split into 3 parts:
Part 1 discusses getting started with the process of implementation of NICE Guidance
Part 2 outlines the principles of implementation of NICE guidance
Part 3 discusses the practical steps to implementation of NICE guidance
Feedback is welcomed by 11th February 2009.
Guide
Head and neck cancer (squamous cell carcinoma) - cetuximab (appraisal consultation document) (29th January 2009)
The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck. Closing date for comments is 19th February 2009.
Consultation
Promoting mental wellbeing at work: consultation on the evidence, January 2009 (29th January 2009)
The aim of this consultation is to enable stakeholders to consider the evidence gathered and to provide the opportunity to comment, in particular on:
- major gaps in the evidence gathered, including papers in the published literature that we have not been able to identify
- queries around the interpretation of the evidence, both of single studies and the reviewed material as a whole
- the applicability of the evidence and its usefulness for the development of guidance
- issues relating to equality
- issues relating to cost-effectiveness
Consultation
Multiple myeloma - lenalidomide: appraisal consultation document 2 (29th January 2009)
The Appraisal Committee has had its second meeting following consultation on the first appraisal consultation document, to consider the updated analysis submitted by the manufacturer. It also considered views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of lenalidomide. Closing date for comments is 20th February 2009.
Consultation
NHS Evidence: draft accreditation process manual public consultation (2nd February 2009)
This draft ‘Process manual for accrediting producers of guidance and recommendations for practice: a guide for producers and stakeholders’ describes the process for accrediting producers of guidance and recommendations for practice. It provides details on the scope for accreditation and what types of guidance producers are accredited, the criteria used to perform the accreditation assessment, the main steps in the process for reaching an accreditation decision and the notification and publication process of an accreditation decision. Closing date for comments is 1st May 2009.
Consultation
Epilepsy (update): scope consultation (3rd February 2009)
NICE have been asked to develop a clinical practice guideline on Epilepsy for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for the Epilepsy (update) guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline. Closing date for comments is 2nd March 2009.
Consultation
No comments:
Post a Comment